Optibiotix signs deal with international food ingredient company SACCO

摘要

OptiBiotix, a leader in the development of human microbiome modulators, has signed a manufacturing and supply agreement with SACCO to market its cholesterol reducing probiotic strain LP LDL~® to the more than 2500 food, beverage, consumer healthcare and pharmaceutical companies it serves across Europe.